Broadfin Capital

Broadfin Capital as of Dec. 31, 2010

Portfolio Holdings for Broadfin Capital

Broadfin Capital holds 44 positions in its portfolio as reported in the December 2010 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alkermes 7.2 $8.4M 687k 12.28
Hi-Tech Pharmacal 6.4 $7.5M 301k 24.95
Pfizer (PFE) 5.5 $6.5M 369k 17.51
Santarus 5.5 $6.5M 2.0M 3.27
Covidien 5.0 $5.9M 130k 45.66
AtriCure (ATRC) 4.6 $5.4M 530k 10.27
Teva Pharmaceutical Industries (TEVA) 4.5 $5.2M 101k 52.13
Sanofi-Aventis SA (SNY) 4.1 $4.8M 149k 32.23
Eurand N V 4.1 $4.8M 403k 11.83
Thoratec Corporation 3.6 $4.3M 150k 28.32
BioMimetic Therapeutics 3.6 $4.2M 330k 12.70
Pain Therapeutics 3.2 $3.7M 555k 6.75
Alere 2.9 $3.3M 91k 36.60
Rigel Pharmaceuticals 2.7 $3.2M 423k 7.53
Lannett Company 2.4 $2.8M 500k 5.59
Anacor Pharmaceuticals In 2.3 $2.7M 509k 5.37
BioSante Pharmaceuticals 2.1 $2.5M 1.5M 1.64
Sequenom 2.1 $2.4M 300k 8.03
Alphatec Holdings 2.0 $2.4M 888k 2.70
Uroplasty 2.0 $2.4M 593k 4.03
MAKO Surgical 1.7 $2.0M 131k 15.22
Qiagen 1.7 $2.0M 100k 19.55
Align Technology (ALGN) 1.6 $1.9M 96k 19.54
Gilead Sciences (GILD) 1.6 $1.8M 50k 36.24
HeartWare International 1.5 $1.8M 20k 87.55
Given Imaging 1.4 $1.6M 109k 14.64
Boston Scientific Corporation (BSX) 1.3 $1.5M 200k 7.57
Impax Laboratories 1.3 $1.5M 75k 20.11
Emergent BioSolutions (EBS) 1.2 $1.4M 59k 23.45
Cardica 1.1 $1.2M 285k 4.38
Orthofix International Nv Com Stk 1.0 $1.1M 39k 28.99
Thermo Fisher Scientific (TMO) 0.9 $1.1M 20k 55.35
Conceptus 0.9 $1.1M 80k 13.81
Qlt 0.9 $1.1M 150k 7.33
King Pharmaceuticals 0.9 $1.1M 75k 14.05
Omnicell (OMCL) 0.8 $997k 69k 14.45
Stereotaxis 0.8 $958k 250k 3.83
Alere 0.8 $893k 3.6k 246.28
Insulet Corporation (PODD) 0.7 $800k 52k 15.50
Solta Medical 0.7 $782k 257k 3.05
Progenics Pharmaceuticals 0.6 $639k 117k 5.46
Inspire Pharmaceuticals 0.5 $538k 64k 8.39
Cutera (CUTR) 0.3 $370k 45k 8.28
OraSure Technologies (OSUR) 0.1 $76k 13k 5.78